Journal profile · Immunology
Autoimmunity Reviews
ISSN 1568-9972 · eISSN 1873-0183 · Elsevier · UNITED STATES · Bimonthly · Founded 2002
Autoimmunity Reviews: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 9.79; hybrid open access; APC about USD 4,730; median 120 days to acceptance (103 articles, last 24 months); community-reported acceptance: fairly hard; 165 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Autoimmunity Reviews is published by Elsevier and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Systemic Lupus Erythematosus Research, T-cell and B-cell Immunology and Systemic Sclerosis and Related Diseases, together about 32.3% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
Autoimmunity Reviews will publish up-to-date, structured reviews on diverse topics in autoimmunity, written by first-class experts in the field. The articles will include demonstrative illustrations and tables and will all have a "take-home" message.Articles will principally be invited by the Editors-in-Chief upon the recommendations of the international Editorial Board, and will cover all fields of autoimmunology, bridging the gap between basic and clinical sciences. Contributions in basic sciences will include those on the pathophysiology and mechanisms of disorders as well as genomics and proteomics; clinical contributions will focus upon the diseases, novel therapies and clinical associations.
From the journal's Aims & Scope
Research area (LetPub): Immunology
Editor-in-chief Andras PerlPublisher website
Editorial board by country: 4 in mainland China (about 5%); most named United States 13, Italy 12, Israel 10, United Kingdom 6, Mainland China 4 (74 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Systemic Lupus Erythematosus ResearchMedicine17.8%
- T-cell and B-cell ImmunologyImmunology and Microbiology8.1%
- Systemic Sclerosis and Related DiseasesMedicine6.4%
- Monoclonal and Polyclonal Antibodies ResearchMedicine6.1%
- Rheumatoid Arthritis Research and TherapiesMedicine5.8%
- Vasculitis and related conditionsMedicine5.4%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology4.3%
- Immune Cell Function and InteractionImmunology and Microbiology4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Immunology | Zone 2 |
Top journal: yesReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Immunology | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Immunology | Zone 2 |
Top journal: yesReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 9.79LetPub ·
- Impact factor (publisher)
- 9.8Publisher website ·
- CiteScore 2026-06
- 15.8LetPub ·
- CiteScore (publisher)
- 15.8Publisher website ·
- SJR 2026-06
- 2.67LetPub ·
- SNIP 2026-06
- 2.85LetPub ·
- h-index
- 103LetPub ·
- h-index
- 195OpenAlex ·
- i10-index
- 2,793OpenAlex ·
- 2-year mean citedness
- 8OpenAlex ·
- Self-citation rate
- 2%LetPub ·
- Share of gold OA articles
- 32.24%LetPub ·
Volume
- Articles per year
- 128LetPub ·
Articles by year OpenAlex count · 3,631 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 149 | 60 | 106 |
| 2025 | 165 | 70 | 1,351 |
| 2024 | 146 | 64 | 2,221 |
| 2023 | 170 | 81 | 4,828 |
| 2022 | 148 | 62 | 4,150 |
| 2021 | 184 | 77 | 8,210 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
120 daysMedian, submission to acceptance · P25–P75 74 days – 208 days
- Acceptance to online
- median 2 days (103 articles)
- Submission to online
- median 127 days
- Sample
- 103 articles with submission and acceptance dates (360 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- Fairly hardLetPub ·
- Submission to first decision
- 2 daysPublisher website ·
- First decision after review
- 42 daysPublisher website ·
- Submission to acceptance
- 82 daysPublisher website ·
- Acceptance to publication
- 3 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,730 / EUR 4,420 / GBP 3,790 / JPY 586,660 | — | — | |
| Publisher website | USD 4,600 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Reference style
- Numbered, in order of citation
- Highlights
- Required
- Graphical abstract
- Optional
Article types accepted7
- letterAutoimmunity Reviews will publish peer-reviewed Review articles of various sizes and formats, but will focus primarily on long review articles that will be doub…Length not stated
- letters to the editorsand Letters to the editors (in order to expedite publication of the letters no proofs will be sent to the authors) is encouraged.Length not stated
- reviewAutoimmunity Reviews will publish peer-reviewed Review articles of various sizes and formats, but will focus primarily on long review articles that will be doub…Length not stated
- review articleAutoimmunity Reviews will publish peer-reviewed Review articles of various sizes and formats, but will focus primarily on long review articles that will be doub…Length not stated
- review articlesAutoimmunity Reviews will publish peer-reviewed Review articles of various sizes and formats, but will focus primarily on long review articles that will be doub…Length not stated
- technical noteAutoimmunity Reviews will publish peer-reviewed Review articles of various sizes and formats, but will focus primarily on long review articles that will be doub…Length not stated
- technical notesThe submission of Technical notes (short application notes, being pages of type plus references and 2-3 display items)Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of one reviewer for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Rea…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2002
- ISSN
- 1568-9972
- Electronic ISSN
- 1873-0183
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Autoimmunity Reviews
What CAS zone is Autoimmunity Reviews in?
In the 2025 upgraded edition of the CAS Journal Ranking, Autoimmunity Reviews is in Zone 1 of Medicine, and in Zone 2 of the minor category Immunology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Autoimmunity Reviews?
The latest impact factor listed by LetPub is 9.79; CiteScore 15.8, h-index 195.
How long does peer review take at Autoimmunity Reviews?
Based on the dates recorded on 103 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 120 days (interquartile range 74–208 days); authors report an average review time of 3–8 weeks; the community-reported acceptance is “Fairly hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Autoimmunity Reviews?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Reference style: Numbered, in order of citation; Highlights: Required; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Autoimmunity Reviews based?
Of the 74 board members whose country the journal's board page names, 4 (about 5%) are in mainland China; the countries named most often are United States (13), Italy (12) and Israel (10). Counted from the institutions listed on the board page; for reference only.
Which databases index Autoimmunity Reviews?
According to LetPub and DOAJ records, Autoimmunity Reviews is indexed in SCIE and Scopus.
Is Autoimmunity Reviews open access, and what is the APC?
Autoimmunity Reviews is a hybrid journal. For open-access publication: APC about USD 4,730.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .